Skip to content

Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease

ENGAGE-PD: Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05022147
Acronym
ENGAGE-PD
Enrollment
12
Registered
2021-08-26
Start date
2021-10-04
Completion date
2026-12-01
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accidental Fall, Deep Brain Stimulation, Disease Progression, Gait Disorders, Neurologic, Parkinson Disease, Subthalamic Nucleus

Keywords

Postural Instability, Gait Impairment, Freezing of Gait, DBS, Frequency, Low, Alternating, Variable, High

Brief summary

The purpose of this study is to assess how alternating-frequency Deep Brain Stimulation (DBS) works to improve postural instability and gait, while also treating other motor symptoms of Parkinson Disease (PD).

Detailed description

Postural instability, gait impairment, and falls are among the greatest unmet needs in Parkinson disease (PD). A single fall can be catastrophic, and impairments that limit mobility lead to social isolation or depression, and adversely affect bone and cardiovascular health. Unfortunately, postural instability and gait disorders are refractory to current pharmacological and surgical treatments, including deep brain stimulation (DBS). This project will directly address this pressing need. We will recruit participants to perform a gait task, using a new, alternating DBS frequency paradigm, while body movements and neural signals are recorded. The findings will lead to improved therapies to address these symptoms in the future.

Interventions

DEVICEHigh-Frequency-Only Stimulation

Control condition, constant high-frequency DBS stimulation (130Hz)

DEVICELow-Frequency-Only Stimulation

Experimental condition, constant low-frequency DBS stimulation (60 Hz)

DEVICEAlternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation

Experimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 50 seconds for high, and 10 seconds for low, respectively.

DEVICEAlternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation

Experimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 50 seconds for high, and 50 seconds for low, respectively.

DEVICEAlternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation

Experimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 10 seconds for high, and 50 seconds for low, respectively.

DEVICEAlternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation

Experimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 10 seconds for high, and 10 seconds for low, respectively.

DRUGOFF Dopaminergic Medication

All six device interventions will be performed in medication OFF state

DRUGON Dopaminergic Medication

All six device interventions will be performed in medication ON state

Sponsors

James Liao
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

There is only one arm in the study. Participants will be masked to which device intervention is active, but they will not be masked to the medication state.

Intervention model description

On a single day, participants will switch between six DBS frequency conditions. Gait and body kinematics will be monitored during these conditions. The order that participants experience the six conditions will be randomized, and participants will be blinded to the condition. In addition, the assessments will be performed OFF and then repeated ON medication.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Bilateral STN DBS for PD * Medtronic Percept PC implanted DBS battery/pulse generator/recording system * Presence of balance and/or walking impairment and/or freezing of gait * Can walk without assistance, OFF meds, based on yes/no verbal response

Exclusion criteria

* Severity of gait impairment should not require dependency to walker or cane * Cannot tolerate monopolar stimulation at either of the two middle electrode contacts (prerequisite for the recording mode of the DBS) at high frequency (130 Hz) or low frequency (60 Hz). * Concomitant conditions that may affect significantly the evaluation of balance or gait, including orthopedic, rheumatologic or other neurological diseases * Contraindication to physical therapy * Age \< 21 * Diagnosis of dementia * Not agreeable to having video taken of entire research visit

Design outcomes

Primary

MeasureTime frameDescription
Stride Time Coefficient of VariationDuring the interventionMarker of gait instability, derived from kinematic recordings from body-worn wireless sensors.
Percentage of Time with Tremor PresentDuring the interventionMarker of tremor severity, derived from kinematic recordings from body-worn wireless sensors.
Tremor AmplitudeDuring the interventionMarker of tremor severity, derived from kinematic recordings from body-worn wireless sensors.

Secondary

MeasureTime frameDescription
Total Freezing TimeDuring the interventionMarker of gait instability, derived from kinematic recordings from body-worn wireless sensors.
Freezing IndexDuring the interventionMarker of gait instability, derived from kinematic recordings from body-worn wireless sensors.
Gait VelocityDuring the interventionMarker of bradykinesia, derived from kinematic recordings from body-worn wireless sensors.
Step CadenceDuring the interventionMarker of bradykinesia, derived from kinematic recordings from body-worn wireless sensors.
LFP and EEG power spectrum correlation with behavior and kinematicsDuring the interventionNeural recordings (LFP = Local Field Potential and EEG = Electroencephalogram) from the DBS electrode and from EEG electrodes will be analyzed in the frequency domain. Assessed frequency bands will include delta, theta, alpha, beta, and gamma activity. These will be correlated with behavior and kinematic recordings to determine the neural correlates of gait instability and other parkinsonian symptoms.
LFP and EEG connectivity correlation with behavior and kinematicsDuring the interventionNeural recordings (LFP = Local Field Potential and EEG = Electroencephalogram) consist of multiple channels of simultaneously measured electrical activity. Connectivity is a measure of correlations between each pair of recorded and postprocessed channels, at each frequency band, over time. A machine learning algorithm will be trained to correlate the connectivity to behavior and kinematic recordings, to determine the neural correlates of gait instability and other parkinsonian symptoms.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJames Liao, MD PhD

The Cleveland Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026